MRVI earnings: next report 2026-08-10, real EPS beat/miss history, analyst consensus Buy, P/E -9.79. Updated 2026-07-23.
Maravai LifeSciences Holdings (MRVI) Research Hub
Maravai LifeSciences Holdings (MRVI) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 6.53 USD (-6.04%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -9.79, market cap 1.95B. This hub links to the full technical, earnings and options research available for MRVI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 6.53 USD (-6.04%) |
| 52-week range | 4.85 USD – 9.42 USD |
| Trend regime | Range |
| 14-day RSI | 52.3 (Neutral) |
| Trailing P/E | -9.79 |
| Market cap | 1.95B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for MRVI
Covered Call on MRVI: how it works, illustrative setup around the real 6.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MRVI: how it works, illustrative setup around the real 6.53 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MRVI: how it works, illustrative setup around the real 6.53 USD price, max profit/loss, breakeven and when to use it. Educational.
MRVI technical analysis: range, last 6.53 USD, RSI 52.3, 52w range 4.85 USD–9.42 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MRVI in?
Maravai LifeSciences Holdings (MRVI) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MRVI in an uptrend or downtrend?
As of 2026-09-11, MRVI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MRVI's trailing P/E ratio?
MRVI's trailing P/E is -9.79, with a market cap of 1.95B. See the earnings research page for full valuation detail.
When does MRVI next report earnings?
MRVI is next scheduled to report earnings on 2026-08-10, with a consensus EPS estimate of -0.05 USD.